Last reviewed · How we verify
NCT05367869: methylene
Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy
NA trial testing Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy in Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy in 40 participants. Status unknown.
31 May 2023
Quick facts
| Lead sponsor | Qena Oncology Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 June 2022 |
| Primary completion | 31 May 2023 |
| Estimated completion | 31 May 2023 |
Drugs / interventions tested
- Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy
Conditions studied
- Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy — all drugs for Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy →
Sponsor
Qena Oncology Center
Who can join
Adults 15 to 80, any sex, with Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Impact of Intraoperative Spraying methylene blue In thyroidectomy
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05367869
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Qena Oncology Center trials
Trials by the same sponsor.
- NCT05521594 — Accuracy of FNAC in Thyroid Nodules Compared to to Surgical Specimen : QOC Experience · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05367869 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qena Oncology Center
- Last refreshed: 24 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05367869.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing